
How Can Predictive Analytics Transform the Pharma Supply Chain?
Emily Gallo, SVP of OptiFreight® Logistics at Cardinal Health, discusses how predictive analytics and actionable benchmarking bridge the data-to-decision gap in pharma logistics.
In the first installment of her interview with Pharmaceutical Commerce, Emily Gallo, senior vice president and general manager of OptiFreight® Logistics at Cardinal Health discusses the critical intersection of predictive analytics and supply chain logistics.
In the modern pharma supply chain, the primary challenge is no longer a lack of information; it is the sheer volume of it. For many healthcare professionals and logistics teams, the transition from collecting massive datasets to executing timely, informed decisions remains a significant hurdle. As industry demands increase and resources tighten, the ability to predict "what’s around the corner" has become the differentiator between reactive firefighting and long-term operational resiliency. In an era where a single shipment delay can postpone a clinical trial or rare disease therapeutic delivery, the "data-to-decision" gap has moved from a back-office efficiency concern to a front-line strategic priority.
The stakes are particularly high within the specialized world of pharma logistics, where fragmented supplier networks and the high sensitivity of products—ranging from
Gallo highlights how organizations are moving beyond basic data collection to implement actionable benchmarking and machine-learning tools. Throughout her conversation, she sheds light on how predictive insights do more than just protect the bottom line—they ensure the integrity of life-saving products and drive the long-term success of the health systems they support.




